Adicet Bio, Inc. Earnings Per Share (Basic)
Adicet Bio, Inc. (ACET) reported Earnings Per Share (Basic) of -$1.99 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-05
- Adicet Bio, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$1.99.
- Adicet Bio, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$1.88.
- Adicet Bio, Inc. earnings per share, basic for the quarter ending 2025-12-31 was $0.12, a 2.89% increase year-over-year.
- Adicet Bio, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.29.
- Adicet Bio, Inc. earnings per share, basic for fiscal 2025 was -$16.95.
- Adicet Bio, Inc. earnings per share, basic for fiscal 2024 was -$21.33.
- Adicet Bio, Inc. earnings per share, basic for fiscal 2023 was -$3.31.
- Adicet Bio, Inc. earnings per share, basic for fiscal 2022 was -$1.70.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.99 10-Q · filed 2026-08-05 | -$3.87 10-Q · filed 2026-08-05 | $0.96 derived: net income ÷ weighted average shares · filed 2026-08-05 | $2.96 derived: net income ÷ weighted average shares · filed 2026-08-05 | |||
| 2026-03-31 | -$1.88 10-Q · filed 2026-05-13 | $0.43 derived: net income ÷ weighted average shares · filed 2026-05-13 | $1.61 derived: net income ÷ weighted average shares · filed 2026-05-13 | $3.14 derived: net income ÷ weighted average shares · filed 2026-08-05 | |||
| 2025-12-31 | $0.12 derived: net income ÷ weighted average shares · filed 2026-03-12 | $0.74 derived: net income ÷ weighted average shares · filed 2026-03-12 | $1.78 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$16.95 10-K · filed 2026-03-12 | |||
| 2025-09-30 | -$0.29 10-Q · filed 2025-11-05 | -$1.20 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$0.94 10-Q · filed 2025-11-05 | $3.38 derived: net income ÷ weighted average shares · filed 2026-08-05 | |||
| 2025-06-30 | -$5.48 10-Q · filed 2026-08-05 | -$0.34 10-Q · filed 2025-08-07 | -$10.40 10-Q · filed 2026-08-05 | -$0.65 10-Q · filed 2025-08-07 | $1.16 derived: net income ÷ weighted average shares · filed 2026-08-05 | $3.48 derived: net income ÷ weighted average shares · filed 2026-08-05 | |
| 2025-03-31 | -$4.96 10-Q · filed 2026-05-13 | -$0.31 10-Q · filed 2025-05-06 | $0.49 derived: net income ÷ weighted average shares · filed 2026-05-13 | $1.85 derived: net income ÷ weighted average shares · filed 2026-05-13 | $9.12 derived: net income ÷ weighted average shares · filed 2026-05-13 | ||
| 2024-12-31 | $0.12 derived: net income ÷ weighted average shares · filed 2026-03-12 | $0.80 derived: net income ÷ weighted average shares · filed 2026-03-12 | $4.68 derived: net income ÷ weighted average shares · filed 2026-03-12 | -$21.33 10-K · filed 2026-03-12 | -$1.33 10-K · filed 2025-03-06 | ||
| 2024-09-30 | -$0.34 10-Q · filed 2025-11-05 | -$0.67 derived: net income ÷ weighted average shares · filed 2025-11-05 | -$1.02 10-Q · filed 2025-11-05 | -$1.55 derived: net income ÷ weighted average shares · filed 2025-11-05 | |||
| 2024-06-30 | -$0.33 10-Q · filed 2025-08-07 | -$0.68 10-Q · filed 2025-08-07 | -$1.23 derived: net income ÷ weighted average shares · filed 2025-08-07 | -$2.15 derived: net income ÷ weighted average shares · filed 2025-08-07 | |||
| 2024-03-31 | -$0.35 10-Q · filed 2025-05-06 | -$0.94 derived: net income ÷ weighted average shares · filed 2025-05-06 | -$1.95 derived: net income ÷ weighted average shares · filed 2025-05-06 | -$2.69 derived: net income ÷ weighted average shares · filed 2025-05-06 | |||
| 2023-12-31 | -$0.68 derived: net income ÷ weighted average shares · filed 2025-03-06 | -$1.84 derived: net income ÷ weighted average shares · filed 2025-03-06 | -$2.60 derived: net income ÷ weighted average shares · filed 2025-03-06 | -$3.31 10-K · filed 2025-03-06 | |||
| 2023-09-30 | -$1.16 10-Q · filed 2024-11-06 | -$1.92 derived: net income ÷ weighted average shares · filed 2024-11-06 | -$2.63 10-Q · filed 2024-11-06 | -$3.33 derived: net income ÷ weighted average shares · filed 2024-11-06 | |||
| 2023-06-30 | -$0.75 10-Q · filed 2024-08-13 | -$1.47 10-Q · filed 2024-08-13 | -$2.17 derived: net income ÷ weighted average shares · filed 2024-08-13 | -$2.71 derived: net income ÷ weighted average shares · filed 2024-08-13 | |||
| 2023-03-31 | -$0.72 10-Q · filed 2024-05-14 | -$1.42 derived: net income ÷ weighted average shares · filed 2024-05-14 | -$1.95 derived: net income ÷ weighted average shares · filed 2024-05-14 | -$2.52 derived: net income ÷ weighted average shares · filed 2024-05-14 | |||
| 2022-12-31 | -$0.70 derived: net income ÷ weighted average shares · filed 2024-03-19 | -$1.23 derived: net income ÷ weighted average shares · filed 2024-03-19 | -$1.79 derived: net income ÷ weighted average shares · filed 2024-03-19 | -$1.70 10-K · filed 2024-03-19 | |||
| 2022-09-30 | -$0.53 10-Q · filed 2023-11-08 | -$1.09 derived: net income ÷ weighted average shares · filed 2023-11-08 | -$0.98 10-Q · filed 2023-11-08 | -$1.43 derived: net income ÷ weighted average shares · filed 2023-11-08 | |||
| 2022-06-30 | -$0.56 10-Q · filed 2023-08-09 | -$0.45 10-Q · filed 2023-08-09 | -$0.89 derived: net income ÷ weighted average shares · filed 2023-08-09 | -$1.31 derived: net income ÷ weighted average shares · filed 2023-08-09 | |||
| 2022-03-31 | $0.12 10-Q · filed 2023-05-09 | -$0.30 derived: net income ÷ weighted average shares · filed 2023-05-09 | -$0.72 derived: net income ÷ weighted average shares · filed 2023-05-09 | -$1.05 derived: net income ÷ weighted average shares · filed 2023-05-09 | |||
| 2021-12-31 | -$0.47 derived: net income ÷ weighted average shares · filed 2023-03-15 | -$0.91 derived: net income ÷ weighted average shares · filed 2023-03-15 | -$1.25 derived: net income ÷ weighted average shares · filed 2023-03-15 | -$2.00 10-K · filed 2023-03-15 | |||
| 2021-09-30 | -$0.44 10-Q · filed 2022-11-08 | -$0.78 derived: net income ÷ weighted average shares · filed 2022-11-08 | -$1.54 10-Q · filed 2022-11-08 | ||||
| 2021-06-30 | -$0.34 10-Q · filed 2022-08-10 | -$1.11 10-Q · filed 2022-08-10 | |||||
| 2021-03-31 | -$0.82 10-Q · filed 2022-05-12 | ||||||
| 2020-12-31 | -$5.01 derived: net income ÷ weighted average shares · filed 2022-03-15 | ||||||
| 2019-12-31 | -$13.10 derived: net income ÷ weighted average shares · filed 2021-03-12 | ||||||
| 2018-12-31 | -$4.54 derived: net income ÷ weighted average shares · filed 2021-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |